Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy

INTRODUCTION: There are no clinically validated prognostic biomarkers in the management of extensive-stage SCLC (ES-SCLC). We explored the association between clinical characteristics and survival outcomes in patients with ES-SCLC treated with chemoimmunotherapy. METHODS: In this retrospective cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Mathai, Jared, Alamgeer, Muhammad, Parakh, Sagun, Paul, Eldho, Mitchell, Paul, Arulananda, Surein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388193/
https://www.ncbi.nlm.nih.gov/pubmed/37529402
http://dx.doi.org/10.1016/j.jtocrr.2023.100544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388193/
https://www.ncbi.nlm.nih.gov/pubmed/37529402
http://dx.doi.org/10.1016/j.jtocrr.2023.100544

Ejemplares similares